Inventor · disambiguated record
Xuesong Xu
Also filed as: XU XUESONG
20 granted patents·3 pending applications·537 citations·filing 2016–2024
96Inventor score
Top patents by PatentIndex Score
23 records- 0198US10941107B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2020·Granted Mar 9, 2021·36 cites·26 claims
- 0298US10882832B2Bicyclic heteroaryl derivatives and preparation and uses thereofXW LAB INC·Filed 2020·Granted Jan 5, 2021·36 cites·30 claims
- 0398US10774031B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2020·Granted Sep 15, 2020·57 cites·29 claims
- 0498US10640451B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2019·Granted May 5, 2020·52 cites·30 claims
- 0598US10640476B2Bicyclic heteroaryl derivatives and preparation and uses thereofXW LAB INC·Filed 2019·Granted May 5, 2020·36 cites·16 claims
- 0698US10501401B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2019·Granted Dec 10, 2019·60 cites·30 claims
- 0798US10457627B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2016·Granted Oct 29, 2019·61 cites·32 claims
- 0897US10968202B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2020·Granted Apr 6, 2021·38 cites·15 claims
- 0997US10836714B2Ketamine derivatives and compositions thereofXW LAB INC·Filed 2020·Granted Nov 17, 2020·41 cites·30 claims
- 1097US10730853B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2020·Granted Aug 4, 2020·38 cites·12 claims
- 1197US10683262B2Ketamine derivatives and compositions thereofXW LAB INC·Filed 2019·Granted Jun 16, 2020·40 cites·25 claims
- 1297US10618886B1Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2019·Granted Apr 14, 2020·38 cites·12 claims
- 1393US11420955B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXWPHARMA LTD·Filed 2021·Granted Aug 23, 2022·2 cites·14 claims
- 1492US12209060B2Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2022·Granted Jan 28, 2025·1 cites·24 claims
- 1587US2025122149A1Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1686US11440874B2Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2020·Granted Sep 13, 2022·1 cites·18 claims
- 1781US12172980B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXWPHARMA LTD·Filed 2022·Granted Dec 24, 2024·0 cites·15 claims
- 1879US11639337B2Bicyclic heteroaryl derivatives and preparation and uses thereofXWPHARMA LTD·Filed 2022·Granted May 2, 2023·0 cites·13 claims
- 1974US2021130281A1Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXWPHARMA LTD·Filed 2021·Application pending·0 cites
- 2072US11401249B2Bicyclic heteroaryl derivatives and preparation and uses thereofXWPHARMA LTD·Filed 2020·Granted Aug 2, 2022·0 cites·12 claims
- 2170US11905247B2Compounds as neurokinin-1 receptor antagonists and uses thereofXWPHARMA LTD·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 2266US2024092727A1Crystalline 4-((l-valyl)oxy)butanoic acidXWPHARMA LTD·Filed 2023·Application pending·0 cites
- 2363US11149006B2Compounds as neurokinin-1 receptor antagonists and uses thereofXW LAB INC·Filed 2020·Granted Oct 19, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Xuesong Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →